image
Lyra Therapeutics, Inc. LYRA
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.17
-5.56 %
$ 11.1 M
Market Cap
-0.11
P/E
BALANCE SHEET
143 M ASSETS
29.67%
Growth Rates
1Year 29.67%
3Years 20.83%
5Years 41.25%
7Years 0.00%
10Years 0.00%
53.2 M LIABILITIES
82.04%
Growth Rates
1Year 82.04%
3Years 103.20%
5Years -16.68%
7Years 0.00%
10Years 0.00%
89.4 M EQUITY
10.73%
Growth Rates
1Year 10.73%
3Years 6.28%
5Years 23.17%
7Years 0.00%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Lyra Therapeutics, Inc.
image
Current Assets 105 M
Cash & Short-Term Investments 103 M
Receivables 0
Other Current Assets 2.07 M
Non-Current Assets 37.8 M
Long-Term Investments 0
PP&E 35.3 M
Other Non-Current Assets 2.5 M
Current Liabilities 19.6 M
Accounts Payable 3.13 M
Short-Term Debt 10.9 M
Other Current Liabilities 5.6 M
Non-Current Liabilities 33.6 M
Long-Term Debt 21.4 M
Other Non-Current Liabilities 12.1 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018
ASSETS
Cash & Cash Equivalents 22.4 32.5 45.7 74.6 9.8 23.9
Short Term Investments 80.4 65.3 0 0 0 0
Receivables 0 0 0 0 0 0.2
Inventory 0 0 0 0 0 1
Other Current Assets 2.1 2.9 4.3 2.6 0.3 0.9
Total Current Assets 104.8 100.8 47.9 75.9 10.1 24.9
PP&E 35.3 4.5 5.9 4.5 3.4 0.1
Intangible Assets 0 0 0 0 0 0
Goodwill 0 0 0 0 0 0
Long Term Investments 0 1.4 0.3 0.3 0.3 0.3
Other Long Term Assets 2.5 3.3 0.8 0.1 1.1 0
Other Assets 0 0 0 0 0 0
Total Assets 142.6 110.0 54.9 80.8 15.0 25.4
LIABILITIES
Accounts Payable 3.1 2.6 3.1 0.9 1.1 0.6
Short Term Debt 10.9 3.5 2.1 2.0 0.9 0
Other Current Liabilities 3.9 9.0 3.2 2.0 3.2 1.3
Total Current Liabilities 19.6 14.5 18.2 4.9 5.2 2.0
Long Term Debt 21.4 0.7 0.4 1.5 2.4 0
Deferred Tax Income 0 (14.1) (1.9) 0 0 0
Other Liabilities 0 0 0 0 0 130.5
Total Liabilities 53.2 29.2 20.6 6.3 7.6 132.4
EQUITY
Common Stock 57 K 32 K 13 K 13 K 6 K 6 K
Retained Earnings (311.4) (248.7) (193.4) (149.9) (127.8) (111.5)
Other Accumulative Comprehensive Income/Loss 33 K 10 K 0 (80.8) 0 (2.8)
Total Equity 89.4 80.8 34.3 74.5 7.3 (107.1)
Total Liabilities and Equity 142.6 110.0 54.9 80.8 15.0 25.4
SHARES OUTSTANDING
Common Shares Outstanding 49.8 30.2 13.0 8.6 12.9 6.3